- Home
- SERA
as 11-08-2024 11:38am EST
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
| Founded: | 2008 | Country: | United States |
| Employees: | N/A | City: | SALT LAKE CITY |
| Market Cap: | 258.3M | IPO Year: | 2021 |
| Target Price: | N/A | AVG Volume (30 days): | 57.4K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.99 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.65 - $12.36 | Next Earning Date: | 11-06-2024 |
| Revenue: | $94,000 | Revenue Growth: | -71.52% |
| Revenue Growth (this year): | -16.67% | Revenue Growth (next year): | 2018.04% |
Stock Insider Trading Activity of Sera Prognostics Inc. (SERA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Mirza Mansoor Raza | SERA | Director | Oct 7 '24 | Sell | $7.15 | 96 | $686.40 | 6,824 | |
| Lindgardt Zhenya | SERA | Chief Executive Officer | Sep 10 '24 | Sell | $7.57 | 25,085 | $189,893.45 | 831,833 | |
| Aerts Austin | SERA | Chief Financial Officer | Sep 10 '24 | Sell | $7.57 | 5,056 | $38,273.92 | 298,665 |
Latest Sera Prognostics Inc. News
SERA Breaking Stock News: Dive into SERA Ticker-Specific Updates for Smart Investing
Simply Wall St.
8 hours ago
Sera Prognostics (NASDAQ:SERA) Is In A Strong Position To Grow Its Business
Simply Wall St.
8 hours ago
Sera Prognostics Third Quarter 2024 Earnings: Misses Expectations
Zacks
2 days ago
Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Lags Revenue Estimates
PR Newswire
2 days ago
SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS
PR Newswire
11 days ago
Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024
PR Newswire
2 months ago
Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference
PR Newswire
3 months ago
Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024
Zacks
3 months ago
Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates
Compare SERA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "SERA Sera Prognostics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.